27 March 2001
Source: http://www.access.gpo.gov/su_docs/aces/fr-cont.html
-------------------------------------------------------------------------
[Federal Register: March 27, 2001 (Volume 66, Number 59)]
[Notices]
[Page 16678]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27mr01-66]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Epidemiology Research Needs Related to the Radiofrequency Energy
From Wireless Phones
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing a public
meeting to discuss the health effects of radio frequency (RF) emissions
from wireless phones. Currently, the scientific literature relating to
the health effects of low level exposure to RF does not demonstrate the
existence of any health risk from wireless phones. National and
international scientific experts will discuss the need for research
into the incidence, distribution, and control of any adverse effects
related to RF energy from wireless phones. This meeting is being
convened as part of the Cooperative Research and Development Agreement
(CRADA) between FDA's Center for Devices and Radiological Health and
the Cellular Telecommunications Industry Association (CTIA).
Date and Time: The meeting will be held on April 18, 2001, 8:30
a.m. to 5 p.m. and on April 19, 2001, 8:30 a.m. to 5 p.m.
Location: The meeting will be held at The Regal Cincinnati Hotel,
Colonnada B, second floor, 150 West Fifth St., Cincinnati, OH.
Contact: Russell D. Owen, Center for Devices and Radiological
Health, Food and Drug Administration (HFZ-114), 12709 Twinbrook Pkwy.,
Rockville, MD 20857, 301-443-7118, FAX 301-594-6775. Further
information about the CRADA is available on the Internet at: http://
www.fda.gov/cdrh/ocd/wlessphonecrada.html.
Agenda: On April 18, 2001, completed and ongoing epidemiology
studies will be reviewed and scientific questions that have been raised
by this research will be discussed. On April 19, 2001, specific studies
that could address these scientific questions will be discussed.
Procedure: Interested persons may present scientific information
relevant to items on the agenda. Written submissions may be made to the
contact person by April 6, 2001. Oral presentations from the public
will be scheduled on April 18, 2001, between 3 p.m. and 5 p.m. Time
allotted for each presentation may be limited. Those desiring to make
formal oral presentations should notify the contact person before April
1, 2001, and submit a brief statement of the general nature of the
information they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
Transcripts: Transcripts of the meeting may be requested in writing
from the Freedom of Information Office (HFI-35), Food and Drug
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857,
approximately 15 working days after the meeting at a cost of 10 cents
per page.
If you need special accommodations due to a disability, please
contact Abiy B. Desta, 301-443-7192 at least 7 days in advance.
Dated: March 20, 2001.
Ann M. Witt,
Acting Associate Commissioner for Policy.
[FR Doc. 01-7447 Filed 3-26-01; 8:45 am]
BILLING CODE 4160-01-S